#United States #Norman #HealthTech #Venture Studio #Boyd Street Capital

Boyd Street Capital Launches HealthTech Platform Fund II

Boyd Street Capital has officially announced the launch of its HealthTech Platform Fund II, targeting growth investments of up to $100 million. The fund is specifically aimed at empowering healthcare technology companies that are in growth stages, particularly those focusing on innovations in fields such as artificial intelligence, digital health, medical devices, diagnostics, and healthcare software.

This launch marks a significant milestone in the firm’s ambitious Mission 2030 strategy, which aims to create a globally interconnected platform for healthcare innovation. Boyd Street Capital seeks to transform the way healthcare innovations are developed and implemented, creating an ecosystem that bridges the gaps between research institutions, health systems, and industry leaders.

As part of this initiative, HealthTech Platform Fund II will not only serve as a source of vital growth capital but will also function as a comprehensive support system for the broader healthcare innovation platform. This unique approach connects various stakeholders, including entrepreneurs and investors, into a collaborative ecosystem designed to hasten the journey of innovative solutions from conception to clinical application.

To spearhead this promising venture, Boyd Street Capital has appointed Lisa Risser as the General Partner of HealthTech Platform Fund II. Risser brings with her a wealth of experience, boasting over thirty years in executive leadership roles with major health systems. Her expertise will guide the fund’s investment strategy and ensure strong collaboration with the portfolio companies in the healthcare landscape.

The firm envisions HealthTech Platform Fund II as the engine driving the commercialization of healthcare technologies. Unlike traditional venture capital models, Boyd Street Capital’s approach goes beyond merely providing financial backing. With the inclusion of an integrated Venture Studio, the fund offers hands-on assistance in areas such as strategic partnerships, regulatory planning, executive recruitment, and operational scaling to its portfolio companies.

James Spann, the Founder and CEO of Boyd Street Capital, articulated the critical nature of this initiative. He stated, “Healthcare is entering one of the most transformative periods in its history.” He emphasized the significant opportunities available for entrepreneurs amid the convergence of new technologies like artificial intelligence and precision medicine, indicating that HealthTech Platform Fund II could serve as a pivotal resource for those innovators.

Investment focus areas for HealthTech Platform Fund II include:

• - Artificial Intelligence and Clinical Decision Support
• - Digital Health and Virtual Care
• - Medical Devices and Diagnostics
• - Healthcare Software and Infrastructure
• - Innovations in Care Delivery and Healthcare Data Analytics

The mission of Boyd Street Capital extends into the international arena, where it aims to facilitate cross-border commercialization initiatives. The firm intends to bring advanced technologies developed outside the United States into the competitive U.S. healthcare market and assist American healthcare innovations in finding new avenues for growth abroad through strategic partnerships and platform enhancements.

As they build out this exciting venture, Boyd Street Capital is poised to announce additional initiatives supporting its HealthTech Platform in the upcoming months. The firm is committed to connecting health systems, research entities, entrepreneurs, and investors in a unified platform to speed up the commercialization of transformative healthcare solutions and ultimately improve patient outcomes around the globe.

For founders, strategic partners, and interested investors, further details about HealthTech Platform Fund II can be found on Boyd Street Capital’s website at www.boydstreetcap.com.

In summary, the launch of HealthTech Platform Fund II signifies Boyd Street Capital's ambition to lead the next wave of healthcare innovation, and with experienced leadership in place, it is set to make a substantial impact in the global healthcare landscape.